Literature DB >> 3163236

Conversion of xanthine dehydrogenase to oxidase in ischemic rat intestine: a reevaluation.

D A Parks1, T K Williams, J S Beckman.   

Abstract

Oxygen radicals derived from xanthine oxidase (XO) are important mediators of the cellular injury associated with reperfusion of ischemic intestine, stomach, liver, kidney, and pancreas. XO exists in nonischemic tissue predominantly as xanthine dehydrogenase (XDH) and converts to oxygen radical-producing XO with ischemia. Grinding intestine under liquid nitrogen and placing the powder in phosphate buffer (pH 7.0) containing thiol reductants and protease inhibitors adequately preserved total XDH + XO activity and the percentage in the oxidase form (%XO) for 24 h. Total activity in nonischemic intestine ranged from 374 nmol.min-1.g-1 in duodenum to 138 nmol.min-1.g-1 in ileum, while XO activity was approximately 19% of total activity throughout the entire small intestine. The rate of XDH conversion to XO during normothermic ischemia varied only slightly throughout the intestine, increasing 13% per hour to 34, 46, and 61% XO after 1, 2, and 3 h of ischemia, respectively. Our results contrast with previous reports where XDH conversion to XO occurred within 60 s ischemia but are consistent with physiological and morphological evidence of ischemic injury and provide further support for involvement of XO in intestinal injury associated with ischemia.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3163236     DOI: 10.1152/ajpgi.1988.254.5.G768

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  66 in total

1.  In vitro ischemia-reperfusion injury in term human placenta as a model for oxidative stress in pathological pregnancies.

Authors:  T H Hung; J N Skepper; G J Burton
Journal:  Am J Pathol       Date:  2001-09       Impact factor: 4.307

2.  Aldehyde oxidase functions as a superoxide generating NADH oxidase: an important redox regulated pathway of cellular oxygen radical formation.

Authors:  Tapan K Kundu; Murugesan Velayutham; Jay L Zweier
Journal:  Biochemistry       Date:  2012-03-19       Impact factor: 3.162

Review 3.  Oxygen radicals: mediators of gastrointestinal pathophysiology.

Authors:  D A Parks
Journal:  Gut       Date:  1989-03       Impact factor: 23.059

Review 4.  Ultra-endurance exercise and oxidative damage : implications for cardiovascular health.

Authors:  Wade L Knez; Jeff S Coombes; David G Jenkins
Journal:  Sports Med       Date:  2006       Impact factor: 11.136

5.  Neuroprotective effect of etomidate in the central nervous system of streptozotocin-induced diabetic rats.

Authors:  Ozkan Ates; Neslihan Yucel; Suleyman R Cayli; Eyup Altinoz; Saim Yologlu; Ayhan Kocak; Celal Ozbek Cakir; Yusuf Turkoz
Journal:  Neurochem Res       Date:  2006-06-21       Impact factor: 3.996

6.  Edematous Bullae: An Atypical Presentation of Reperfusion Injury. A Discussion of Ischemic-reperfusion Injury and Presentation of an Atypical Case.

Authors:  Manick Saran; Sean Malarkey
Journal:  Cureus       Date:  2019-08-13

7.  The role of xanthine oxidase in platelet activating factor induced intestinal injury in the rat.

Authors:  X W Qu; R A Rozenfeld; W Huang; G B Bulkley; W Hsueh
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

8.  Nitrite confers protection against myocardial infarction: role of xanthine oxidoreductase, NADPH oxidase and K(ATP) channels.

Authors:  John E Baker; Jidong Su; Xiangping Fu; Anna Hsu; Garrett J Gross; James S Tweddell; Neil Hogg
Journal:  J Mol Cell Cardiol       Date:  2007-07-31       Impact factor: 5.000

Review 9.  Ischemia-reperfusion injury of the intestine and protective strategies against injury.

Authors:  Ismail Hameed Mallick; Wenxuan Yang; Marc C Winslet; Alexander M Seifalian
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

Review 10.  Xanthine oxidoreductase-catalyzed reduction of nitrite to nitric oxide: insights regarding where, when and how.

Authors:  Nadiezhda Cantu-Medellin; Eric E Kelley
Journal:  Nitric Oxide       Date:  2013-02-27       Impact factor: 4.427

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.